| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/24/1992 | EP0444158A4 Conjugated polypeptides and methods for their preparation and use |
| 06/24/1992 | EP0396617B1 Paramagnetic compounds |
| 06/23/1992 | US5124267 Complexing with antibody; mass spectrometry |
| 06/23/1992 | US5123414 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 06/23/1992 | CA1303978C Injectable opacifying composition containing liposomes of high encapsulation capacity for x-ray examinations |
| 06/22/1992 | WO1992011232A1 Chelating agents |
| 06/22/1992 | CA2098712A1 Chelating agents |
| 06/18/1992 | WO1992011493A1 Balanced pressure solid fuel heating unit |
| 06/18/1992 | WO1992011055A1 Vascular catheter having low-profile distal end |
| 06/18/1992 | CA2098592A1 Balanced pressure solid fuel heating unit |
| 06/17/1992 | EP0489869A1 Hydroxy-aryl metal chelates for diagnostic nmr imaging |
| 06/17/1992 | EP0185680B1 Steroidal liposomes |
| 06/16/1992 | US5122603 Purified insulin mediators and purification process for same |
| 06/16/1992 | US5122363 Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 06/15/1992 | CA2056835A1 Hydrophilic form of perfluoro compounds and methods of manufacture |
| 06/12/1992 | WO1992010166A1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
| 06/11/1992 | WO1992009610A1 Drug delivery porphyrin compositions and methods |
| 06/10/1992 | EP0310645B1 Compounds useful particularly for radiotherapy or imaging of cancer |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120642 Medical diagnosis |
| 06/09/1992 | US5120527 Paramagnetic oil emulsions as mri contrast agents |
| 06/08/1992 | WO1992010213A1 Molecular sieve-enclosed paramagnetic ion for diagnosis |
| 06/07/1992 | CA2057189A1 Contrast agent made of a neutral complex of paramagnetic cation and ligand to make a complex |
| 06/03/1992 | EP0488200A1 Sheet for assisting in NMR diagnosis |
| 06/03/1992 | EP0488024A1 Aid for examination of the small intestine |
| 06/03/1992 | EP0487718A1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety |
| 06/03/1992 | EP0467954A4 Preparation of liposome and lipid complex compositions |
| 06/02/1992 | US5118614 Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
| 06/02/1992 | US5118499 For topical treatment of rheumatoid arthritis and cancer |
| 05/30/1992 | WO1992009894A1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 05/30/1992 | CA2095237A1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 05/29/1992 | WO1992008725A1 Polyazamacrocyclic compounds for complexation of metal ions |
| 05/29/1992 | WO1992008496A1 Medical ultrasound contrast agent and method of using same |
| 05/29/1992 | WO1992008494A2 Targeting radioactive immunoreagents |
| 05/29/1992 | WO1992008479A1 Tissue factor based prothrombin time reagent |
| 05/29/1992 | WO1992005866A3 Efficient microcapsule preparation and method of use |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0201601B1 Glass microspheres |
| 05/27/1992 | CN1016760B Hypersensitivity test means |
| 05/26/1992 | US5116599 Imaging compounds for medical diagnosis |
| 05/26/1992 | US5116328 Diagnostic kit for the detection of atypical epithelia |
| 05/22/1992 | WO1992009884A1 Alkoxyamide derivatized chelates for mri |
| 05/22/1992 | WO1992009562A1 Novel x-ray contrast agents, compositions and methods |
| 05/22/1992 | CA2096543A1 Alkoxyamide derivatized chelates for mri |
| 05/22/1992 | CA2095927A1 X-ray contrast agents, compositions and methods |
| 05/20/1992 | EP0485563A1 Polyether-substituted tumor agents. |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485429A1 Contrast medium composition |
| 05/20/1992 | EP0274467B1 Hepatocyte directed vesicle delivery system |
| 05/20/1992 | EP0216864B1 Detection of activated platelets with antibodies to cell surface antigens |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114703 Medical diagnosis by injection with nonradioactive contrast and imaging |
| 05/19/1992 | CA1301248C Magnetic resonance imaging |
| 05/19/1992 | CA1301063C Biologically degradable superparamagnetic materials for use in clinicalapplications |
| 05/17/1992 | WO1992008691A1 1,3-bis-[3-(mono- or poly-hydroxy)acylamino-5-(mono- or poly-hydroxyalkyl)aminocarbonyl-2,4,6-triiodo-benzoyl-amino]-hydroxy- or hydroxyalkyl-propanes, their methods of preparation and x-ray contrast media containing them |
| 05/17/1992 | CA2096136A1 1,3-bis-[3-(mono- or poly-hydroxy)acylamino-5- (mono- or poly-hydroxyalkyl)aminocarbonyl-2,4,6- triiodo-benzoyl-amino]-hydroxy- or hydroxyalkyl-propanes, their methods of preparation and x-ray contrast media containing them |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/13/1992 | EP0485045A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them |
| 05/13/1992 | EP0484369A1 Modified bioluminescent proteins and their use |
| 05/13/1992 | EP0484328A1 Process for the preparation of 2,4,6-triiodo-5-amino-n-alkylisophthalamic acid and 2,4,6-triiodo-5-amino-isophthalamide compounds. |
| 05/13/1992 | EP0315670B1 Test patch for demonstrating contact allergy. |
| 05/12/1992 | US5112946 Polypeptides and proteins with mutant segments for treatment of cardiovascular disorders and antitumor agents |
| 05/12/1992 | US5112597 Radical lithium phthalocyanine crystals, their preparation process and their use for the in vivo determination of molecular oxygen |
| 05/12/1992 | US5112596 A composition of a neuropharmaceutical or diagnostic agent, a bradykinin agonist to increase blood brain barrier permeability |
| 05/09/1992 | CA2095123A1 Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
| 05/09/1992 | CA2055093A1 Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives, process for their production and pharmaceutical agents containing these derivatives |
| 05/08/1992 | WO1992008707A1 Chelating agents |
| 05/08/1992 | CA2095727A1 Chelating agents |
| 05/07/1992 | DE4035187A1 Ultrasound contrast agent, vaccine, diagnostic or therapeutic agent |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483278A1 Particulate contrast media |
| 05/05/1992 | US5110475 Membrane distillation |
| 05/05/1992 | CA1300005C Sterilization of compositions of limited stability |
| 04/30/1992 | WO1992007859A1 Technetium-99m complex for examining the renal function |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006685A1 Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential |
| 04/30/1992 | CA2093929A1 Technetium-99m complex for examining the renal function |
| 04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
| 04/28/1992 | US5108899 Determining opsonin receptor expression on phagocytes and comparing to similar primed sample; kits |
| 04/28/1992 | US5108636 Magnetizable composite particles based on crosslinked organopolysiloxane, process for preparation thereof and their application in biology |
| 04/28/1992 | US5107842 Aqueous dispersion of insoluble fibrous vegetable, mineral or hydrocolloid particles to enhance contrast |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481526A1 Chelants |
| 04/22/1992 | EP0481420A1 Magnetic resonance imaging agent |
| 04/22/1992 | EP0481087A1 Molded body of water-absorbing resin, process for producing molded body, use thereof, and process for preparing water-absorbing resin |
| 04/22/1992 | EP0480970A1 Tcl-5 gene rearrangement involved in t-cell leukemia and melanoma |
| 04/22/1992 | EP0480925A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers. |
| 04/21/1992 | US5106954 Erythropoietin (epo) peptides |
| 04/21/1992 | US5106948 Anticarcinogenic agents |
| 04/17/1992 | WO1992007259A1 Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging |
| 04/17/1992 | CA2094028A1 Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging |
| 04/16/1992 | WO1992006378A1 Self-assembling fluorescent diagnostic agents |
| 04/16/1992 | WO1992006196A1 Gro genes, proteins, and uses thereof |
| 04/16/1992 | WO1992005807A1 Contrast medium comprising a paramagnetic cation associated with a schiff base |
| 04/16/1992 | WO1992005778A1 Ionically cross-linked polymeric microcapsules |